DE3876788T2 - Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. - Google Patents

Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.

Info

Publication number
DE3876788T2
DE3876788T2 DE8888909786T DE3876788T DE3876788T2 DE 3876788 T2 DE3876788 T2 DE 3876788T2 DE 8888909786 T DE8888909786 T DE 8888909786T DE 3876788 T DE3876788 T DE 3876788T DE 3876788 T2 DE3876788 T2 DE 3876788T2
Authority
DE
Germany
Prior art keywords
peptide
product containing
interferon
urine
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888909786T
Other languages
English (en)
Other versions
DE3876788D1 (de
Inventor
Chantal Damais
Danielle Lando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE3876788D1 publication Critical patent/DE3876788D1/de
Application granted granted Critical
Publication of DE3876788T2 publication Critical patent/DE3876788T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888909786T 1987-10-08 1988-10-06 Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. Expired - Lifetime DE3876788T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8713886A FR2621488B1 (fr) 1987-10-08 1987-10-08 Produit comprenant a titre de principes actifs a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hyfroxyuree
PCT/FR1988/000496 WO1989003224A1 (fr) 1987-10-08 1988-10-06 Produit comprenant a titre de principes actifs: a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hydroxyuree

Publications (2)

Publication Number Publication Date
DE3876788D1 DE3876788D1 (de) 1993-01-28
DE3876788T2 true DE3876788T2 (de) 1993-07-01

Family

ID=9355622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888909786T Expired - Lifetime DE3876788T2 (de) 1987-10-08 1988-10-06 Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.

Country Status (7)

Country Link
EP (1) EP0336958B1 (de)
JP (1) JP2537677B2 (de)
AT (1) ATE83382T1 (de)
CA (1) CA1327745C (de)
DE (1) DE3876788T2 (de)
FR (1) FR2621488B1 (de)
WO (1) WO1989003224A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968249A (en) * 1963-01-22 1976-07-06 E. R. Squibb & Sons, Inc. Method of treating malignant neoplastic disease

Also Published As

Publication number Publication date
DE3876788D1 (de) 1993-01-28
JPH02501484A (ja) 1990-05-24
FR2621488A1 (fr) 1989-04-14
ATE83382T1 (de) 1993-01-15
CA1327745C (fr) 1994-03-15
FR2621488B1 (fr) 1990-02-02
EP0336958A1 (de) 1989-10-18
WO1989003224A1 (fr) 1989-04-20
EP0336958B1 (de) 1992-12-16
JP2537677B2 (ja) 1996-09-25

Similar Documents

Publication Publication Date Title
DE3689974T2 (de) Arzneimittel zur Behandlung von Emesis.
DE68909219T2 (de) Behandlung von obesitas.
DE3764926D1 (de) Schaedlingsbekaempfungs- und pflanzenbehandlungsmittel.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DE3686018T2 (de) Betriebsfuehrung von hardwaremitteln.
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
DE3587741T2 (de) Behandlung von Hautkrankheiten.
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
DE3777861D1 (de) Behandlung von gasen.
DE3886517T2 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE3882611T2 (de) Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
DE3876788D1 (de) Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.
DE3761048D1 (de) Umsetzungsprodukte von bis-glycidylthioethern.
FI854839A0 (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
DE3869939D1 (de) Biologisch wirksame peptide.
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.
DE3783218T2 (de) Fermentationsanaloge von virginiamycin-m1.
DE3780388D1 (de) Fsh-stimulierendes peptid.
DE3673072D1 (de) Behandlung von lignocellulosematerialien.
DE3782199T2 (de) Biologisch aktive peptide tan-866.
IT8619458A0 (it) Prodotti per il trattamento del cuoio.
DE3667518D1 (de) Behandlung von archivmaterial.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN